Pembrolizumab and Olaparib in Cervical Cancer Patients
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-07-23
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- John Diaz
- Target Recruit Count
- 8
- Registration Number
- NCT04483544
- Locations
- 🇺🇸
Miami Cancer Institute at Plantation, Plantation, Florida, United States
🇺🇸Miami Cancer Institute, Miami, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath